Evangelos Terpos, MD, PhD is a Professor of Hematology and Scientific Director of Stem Cell Transplantation Unit in the Department of Clinical Therapeutics of the National & Kapodistrian University of Athens, School of Medicine, Athens, Greece.

His research interests include the biology of bone disease in multiple myeloma (MM), the role of modern imaging (WBLDCT and DWI-MRI), of MRD and of circulating tumor cells (CTCs) in MM and other plasma cell neoplasms. In the clinical research era, Dr Terpos is the PI in several investigator-initiated, phase 1/2 studies MM and has participated in most phase 3 studies with novel agents in the myeloma and WM field, including ADCs, bispecific/trispecific antibodies and CAR-T cell therapies. His research work was reported in more than 850 papers in peer-reviewed journals and Dr Terpos has more than 50,000 citations and an h-index of 105 in ISI/Web of Knowledge and more than 70,000 citations and an h-index of 122 in Google Scholar.

Dr Terpos is Councillor of the European Hematology Association (EHA) Board, Chair of the Supervisor Board of the EHA Foundation and member of the Board of the European Myeloma Network (EMN). He is co-chairing the Bone Sub-Committee of the International Myeloma Working Group, he is a member of the Guideline Committees of EHA and of EMN, and he is a member of the Education and Publication Committees of the International Myeloma Society (IMS). Dr Terpos is also the President of the Greek Myeloma Study Group.

He has given lectures at ASH, ASCO, EHA, IMS and EMN annual meetings. He is Associate Editor of American Journal of Hematology and of Clinical Lymphoma, Myeloma & Leukemia (official IMS journal) for Myeloma and member of the Editorial Board of HemaSphere (official EHA journal) and of Blood Cancer Journal.